Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.

Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.

Serine-proteases are important players in the pathogenesis of asthma, promoting inflammation and tissue remodeling. It's also known that many serine protease inhibitors display immunomodulatory properties. TgPI-1 is a Toxoplasma gondii protein that exhibits broad spectrum inhibitory activity ag...

Full description

Bibliographic Details
Main Authors: Ariadna S Soto, Ignacio M Fenoy, Vanesa R Sanchez, Florencia March, Matías D Perrone Sibilia, María de Los Angeles Aldirico, Mariano S Picchio, Nadia Arcon, Patricio L Acosta, Fernando P Polack, Valentina Martin, Alejandra Goldman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5658115?pdf=render

Internet

http://europepmc.org/articles/PMC5658115?pdf=render

Similar Items